Skip to content

Evaluation of the Medex Test for the Detection of Gastrointestinal Disorders

Evaluation of the Medex Test for the Detection of Gastrointestinal Disorders

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12606000338561
Enrollment
200
Registered
2006-08-08
Start date
2006-07-31
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The primary objective is to compare findings achieved by traditional diagnostic procedures with those of the MEDEXTEST in order to define specificity, sensitivity and accuracy of the MEDEXTEST device. Traditional diagnostic procedures include an evaluation by a physician (history and physical examination), Esophagogastroduodenoscopy (EGD) with/without biopsy and Urea Breath Test. The study population will include 200 male and female patients with clinical symptoms of gastroduodenal disorders of similar baseline characteristics (age, BMI and gender). Investigators and Gastroenterologists at Nepean Hospital will refer patients. Eligibility will be determined by satisfying the following inclusion and exclusion criteria. Eligible participants will undergo a baseline evaluation, which includes: written consent, demographic information, medical history, current medications and a physical examination. Participants will undergo the 20-minute MEDEXTEST conducted by a trained Research Assistant. They will be advised of their results at an appointment with their physician following their endodoscopy procedure. The participants will be referred to tests according to clinical and examination findings such as an Esophagogastroduodenoscopy (EGD) (with or without biopsy) and Urea Breath Test. The MEDEXTEST is a non-invasive examination lasting approximately 20 minutes in duration and performed in the following manner: - External measurement of the skin’s electrical resistance of 24 zones located on the participant’s feet and hands. - T.E.N.S stimulation. - A repeated measurement of the 24 zones. - Mathematical processing of the collected information by the help of a previously composed correlative algorithm. - The results will be saved in the operator’s computer memory and, additionally, a printout will be filed in the patient’s source documentation file. At the completion of data collection, a trained physician will make an independent reading from the MEDEXTEST results, with another physician diagnosing the participant based on the traditional procedures. To minimize the risk of bias, all physicians will be blind to their colleague’s diagnosis. A third investigator will compare the diagnosis from the traditional diagnostic procedures against the MEDEXTEST, record test results in participants’ CRF and conduct a follow-up consultation with participant. After the required data is obtained from all study participants of the study site, the results of the MEDEXTEST will be compared with the actual participant’s condition as indicated by the traditional tests, in order to determine the sensitivity, specificity and total accuracy of the device. The estimated duration of the study is 1 year including data analysis and reporting.

Interventions

The MEDEXTEST device is intended to differentiate between normal and abnormal function of the stomach and duodenum. The MEDEXTEST is a non-invasive radiation free device. The examination lasts approximately 20 minutes and is performed in the following manner: 1. External measurement of 24 skin zones located on the limbs. 2. Stimulation of four special skin zones – lasting one minutes each. 3. External measurement of the same 24 zones. The study design is blind, one-armed, comparative, prospect

The MEDEXTEST device is intended to differentiate between normal and abnormal function of the stomach and duodenum. The MEDEXTEST is a non-invasive radiation free device. The examination lasts approximately 20 minutes and is performed in the following manner: 1. External measurement of 24 skin zones located on the limbs. 2. Stimulation of four special skin zones – lasting one minutes each. 3. External measurement of the same 24 zones. The study design is blind, one-armed, comparative, prospective and without a control group. The examination is only conducted once.

Sponsors

Medex Screen (AustralAsia) Pty Ltd
Lead SponsorCommercial sector/Industry

Study design

Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Diagnosis
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

200 male and female outpatients with clinical symptoms of active digestive disease will be enrolled into the study. The recruitment process of study participants will assure that the baseline characteristics (age, BMI and gender) will be similar.

Exclusion criteria

Those patients who are amputees, preganant or suffering form local skin damage in the areas of Medex Test examination.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026